华领医药-B(02552.HK)授出合共2000万份购股权

Core Viewpoint - The company, 华领医药-B, announced the granting of stock options to three executive directors and 71 employees, contingent upon acceptance by the grantees [2] Group 1: Stock Option Plan - The stock option plan was conditionally approved and adopted on August 26, 2018, and has been effective since September 14, 2018 [2] - A total of 20 million new shares, each with a par value of $0.001, will be available for subscription under this stock option plan [2]